STOCK TITAN
  1. Home
  2. Sec-filings
  3. CDT
  4. [ARS] Conduit Pharmaceuticals Inc. SEC Filing

[ARS] Conduit Pharmaceuticals Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Conduit Pharmaceuticals Inc.

ARS Filing - Conduit Pharmaceuticals Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Conduit Pharmaceuticals Inc. (CDT)

Acceptance Date: 2025-07-08T17:24:53.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock CDT logo
CDT Equity

NASDAQ:CDT

CDT Rankings

#6950 Ranked by Market Cap
N/A Ranked by Dividends

CDT Latest News

Feb 24, 2026
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
Feb 20, 2026
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
Jan 2, 2026
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
Oct 17, 2025
CDT Equity Increases Bitcoin Holding
Oct 9, 2025
CDT Equity Inc. Announces Reverse Stock Split

CDT Latest SEC Filings

Feb 24, 2026
[8-K] CDT Equity Inc. Reports Material Event
Feb 24, 2026
[PRE 14A] CDT Equity Inc. Preliminary Proxy Statement
Feb 23, 2026
[Form 4] CDT Equity Inc. Insider Trading Activity
Feb 18, 2026
[SCHEDULE 13G] CDT Equity Inc. Passive Investment Disclosure (>5%)
Feb 10, 2026
[424B3] CDT Equity Inc. Prospectus Filed Pursuant to Rule 424(b)(3)

CDT Stock Data

1.60M
1.82M
Biotechnology
Pharmaceutical Preparations
Link
United States
NAPLES